T2D Research

Huang et al. 2022 Exploring Biomarkers and Transcription Factors in Type 2 Diabetes

Properties2
tagsreference, type-2-diabetes, transcriptomics, single-cell, pbmc, pancreatic-islet
aliasesHuang et al. 2022 Exploring Biomarkers and Transcription Factors in Type 2 Diabetes

3 min read

Huang et al. 2022: Exploring Biomarkers and Transcription Factors in Type 2 Diabetes

Bibliographic Reference

Huang Y, Cai L, Liu X, Wu Y, Xiang Q, Yu R. Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data. Ann Transl Med. 2022;10(18):1017. doi:10.21037/atm-22-4303

Scope

This study combines bulk RNA-seq from pancreatic islets and single-cell RNA-seq from pancreatic tissue to identify diagnostic biomarkers and transcription factor regulators in type 2 diabetes. It is a pancreatic-islet-focused study, not a PBMC study.

Datasets Used

  • GSE41762: Bulk RNA-seq from islet tissue of 57 healthy and 20 T2D participants.
  • E-MTAB-5061: scRNA-seq from pancreatic tissue and islets of 6 healthy controls and 4 T2D donors.

Key Findings

Differentially Expressed Genes

  • 111 DEGs identified in T2D vs. healthy islets (68 up, 43 down; |log2FC| >0.5, P<0.05).
  • DEGs enriched for hormone secretion, MAPK cascade, collagen metabolism, pancreatic secretion, JAK-STAT signaling, and Ras signaling.

Diagnostic Biomarkers

  • Four genes with AUC >0.8 selected via LASSO: SLC2A2 (AUC=0.9), SERPINF1 (AUC=0.83), RASGRP1 (AUC=0.83), CHL1 (AUC=0.83).
  • Nomogram combining all four biomarkers achieved AUC=0.902.
  • SLC2A2 (GLUT2 glucose transporter) is known from neonatal diabetes genetics.
  • SERPINF1 (PEDF) is linked to obesity, insulin resistance, and leptin levels.
  • RASGRP1 is involved in VEGF-mediated angiogenesis and metformin response.
  • CHL1 regulates pancreatic β-cell proliferation via ERK and p53 pathways.

Single-Cell Analysis

  • 1,515 T2D and 1,817 healthy pancreatic cells retained after filtering.
  • 13 cell clusters annotated into 6 cell types: epithelial cells, fibroblasts, neurons, endothelial cells, macrophages, and hepatocytes.
  • SERPINF1 was predominantly expressed in fibroblasts, with higher expression in healthy vs. T2D fibroblasts.

Transcription Factor Regulation

  • NR2F2 identified as a TF specifically active in SERPINF1-high fibroblasts.
  • NFE2L2 was specific to SERPINF1-low fibroblasts.
  • 18 NR2F2 target genes overlapped with T2D DEGs; 4 (SERPINF1, SFRP4, CELA3A, CTRC) were differentially expressed between high/low SERPINF1 fibroblast groups.
  • SERPINF1-high fibroblasts showed activation of PI3K-AKT, interferon-α response, and ROS pathways; SERPINF1-low fibroblasts showed apoptosis, inflammatory response, and myogenesis pathways.

Relevance to PBMC Ancestry Paper

This study uses pancreatic islet tissue, not PBMCs. Its direct relevance is limited to:

  • Providing T2D biomarker candidates (SLC2A2, SERPINF1, RASGRP1, CHL1) for mechanistic context.
  • Demonstrating a bioinformatics pipeline that combines bulk and single-cell transcriptomics.
  • Highlighting pancreatic fibroblast biology and NR2F2 TF regulation in T2D — complementary tissue context to PBMC immune profiling.

This study does not test ancestry-stratified or multi-ancestry effects.

Limitations Acknowledged by Authors

  • Small scRNA-seq sample size (4 T2D, 6 healthy).
  • No clinical sample validation of biomarker panel.
  • No functional experiments on NR2F2 or other key genes.

Graph View

Backlinks